Literature DB >> 1904418

Inhibitory effect of 2-O-octadecylascorbic acid in agglutination assay with concanavalin A; short-term examination of rat urinary bladder carcinogenesis.

M Suzuki1, K Wakabayashi, H Sone, H Kushida, K Sugiyama, T Kakizoe, M Nagao, T Sugimura.   

Abstract

A derivative of ascorbic acid, 2-O-octadecylascorbic acid (CV-3611), is a strong scavenger of active oxygen species. We examined the effect of CV-3611 on a short-term test of bladder carcinogenesis, using concanavalin A (Con A)-dependent agglutination of isolated bladder epithelial cells. Rats were given 0.01% N-butyl-N-(4-hydroxybutyl)nitrosamine (BHBN) for 1 week, and then 5% sodium saccharin or 2% DL-tryptophan or 0.01% BHBN alone or with 0.002, 0.006 or 0.02% CV-3611 for 3 weeks. Treatment with CV-3611 reduced the effects of the bladder tumor promoters sodium saccharin and DL-tryptophan by 48-86 and 65-87%, respectively. CV-3611 also reduced the number of aggregates of bladder epithelial cells from rats treated with BHBN for 4 weeks. These results suggest that CV-3611 has a suppressive effect on rat bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904418      PMCID: PMC5918435          DOI: 10.1111/j.1349-7006.1991.tb01860.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

Review 1.  The role of 8-hydroxyguanine in carcinogenesis.

Authors:  R A Floyd
Journal:  Carcinogenesis       Date:  1990-09       Impact factor: 4.944

2.  Inhibition by 2(3)-tert-butyl-4-hydroxyanisole and other antioxidants of epidermal ornithine decarboxylase activity induced by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  W J Kozumbo; J L Seed; T W Kensler
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

3.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of ornithine decarboxylase activity, DNA synthesis, and tumor promotion in mouse skin by ascorbic acid and ascorbyl palmitate.

Authors:  R C Smart; M T Huang; Z T Han; M C Kaplan; A Focella; A H Conney
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

4.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition.

Authors:  R Kato; T Nakadate; S Yamamoto; T Sugimura
Journal:  Carcinogenesis       Date:  1983-10       Impact factor: 4.944

5.  L-isoleucine and L-leucine: tumor promoters of bladder cancer in rats.

Authors:  Y Nishio; T Kakizoe; M Ohtani; S Sato; T Sugimura; S Fukushima
Journal:  Science       Date:  1986-02-21       Impact factor: 47.728

6.  Skin tumor-promoting activity of benzoyl peroxide, a widely used free radical-generating compound.

Authors:  T J Slaga; A J Klein-Szanto; L L Triplett; L P Yotti; K E Trosko
Journal:  Science       Date:  1981-08-28       Impact factor: 47.728

Review 7.  DNA damage and oxygen radical toxicity.

Authors:  J A Imlay; S Linn
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

8.  Suppression of rat urinary bladder carcinogenesis by alpha-difluoromethylornithine.

Authors:  Y Homma; T Kakizoe; S Samma; R Oyasu
Journal:  J Urol       Date:  1989-06       Impact factor: 7.450

9.  Inhibitory effects of glutathione level-raising agents and D-alpha-tocopherol on ornithine decarboxylase induction and mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  J P Perchellet; M D Owen; T D Posey; D K Orten; B A Schneider
Journal:  Carcinogenesis       Date:  1985-04       Impact factor: 4.944

10.  Correlation of results of agglutination assays with concanavalin A and carcinogenesis experiments on promoters of bladder cancer.

Authors:  T Kakizoe; Y Nishio; M Ohtani; T Niijima; S Sato; T Sugimura
Journal:  Jpn J Cancer Res       Date:  1985-10
View more
  1 in total

1.  Anti-promoting effect of nordihydroguaiaretic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine and sodium saccharin-induced rat urinary bladder carcinogenesis.

Authors:  A Yu; T Hashimura; Y Nishio; H Kanamaru; S Fukuzawa; O Yoshida
Journal:  Jpn J Cancer Res       Date:  1992-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.